Division Of Cardiology Research Articles

Primer on Commonly Occurring MRI Artifacts and How to Overcome Them.

HomeRadioGraphicsVol. 42, No. 3 PreviousNext PhysicsRadioGraphics FundamentalsPrimer on Commonly Occurring MRI Artifacts and How to Overcome ThemChikara Noda, Bharath Ambale Venkatesh, Jennifer D. Wagner, Yoko Kato, Jason M. Ortman, João A. C. Lima Chikara Noda, Bharath Ambale Venkatesh, Jennifer D. Wagner, Yoko Kato, Jason M. Ortman, João A. C. Lima Author AffiliationsFrom the Divisions of Cardiology (C.N., Y.K., J.M.O., J.A.C.L.) and Radiology (B.A.V.), Johns Hopkins University School of Medicine, 600 N Wolfe St, Blalock 524, Baltimore, MD 21287; and Canon Medical Research USA, Cleveland, Ohio (J.D.W.).Address correspondence to J.A.C.L. (e-mail: [email protected]).Chikara NodaBharath Ambale VenkateshJennifer D. WagnerYoko KatoJason M. OrtmanJoão A. C. Lima Published Online:Apr 22 2022https://doi.org/10.1148/rg.210021MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In AbstractVarious artifacts occur at MRI, and MRI technologists and radiologists must know how to identify and avoid these artifacts so they can consistently produce high-quality images.Suggested Readings Hirokawa Y, Isoda H, Maetani YS, Arizono S, Shimada K, Togashi K. MRI artifact reduction and quality improvement in the upper abdomen with PROPELLER and prospective acquisition correction (PACE) technique. AJR Am J Roentgenol 2008;191(4):1154–1158. Crossref, Medline, Google Scholar Huang SY, Seethamraju RT, Patel P, Hahn PF, Kirsch JE, Guimaraes AR. Body MR Imaging: Artifacts, k-Space, and Solutions. RadioGraphics 2015;35(5):1439–1460. Link, Google Scholar Runge M, Ibrahim EH, Bogun F, et al. Metal Artifact Reduction in Cardiovascular MRI for Accurate Myocardial Scar Assessment in Patients With Cardiac Implantable Electronic Devices. AJR Am J Roentgenol 2019;213(3):555–561. Crossref, Medline, Google Scholar Stadler A, Schima W, Ba-Ssalamah A, Kettenbach J, Eisenhuber E. Artifacts in body MR imaging: their appearance and how to eliminate them. Eur Radiol 2007;17(5):1242–1255. Crossref, Medline, Google Scholar Tsuchihashi T. Artifact of MRI [in Japanese]. Nippon Hoshasen Gijutsu Gakkai Zasshi 2003;59(11):1370–1377. Crossref, Medline, Google ScholarArticle HistoryReceived: Feb 1 2021Revision requested: Apr 20 2021Revision received: June 29 2021Accepted: July 9 2021Published online: Apr 22 2022Published in print: May 2022 FiguresReferencesRelatedDetailsCited ByPostsurgical Evaluation of the Pediatric Foot and AnkleMaria PilarAparisi Gómez, AlbertoBazzocchi, PaoloSimoni, Emilio J.Inarejos Clemente2022 | Seminars in Musculoskeletal Radiology, Vol. 26, No. 06Accompanying This ArticlePrimer on Commonly Occurring MRI Artifacts and How to Overcome ThemApr 22 2022Default Digital Object SeriesRecommended Articles Respiratory Motion Management in Abdominal MRI: Radiology In TrainingRadiology2022Volume: 306Issue: 1pp. 47-53Invited Commentary on “Optimizing Diffusion-Tensor Imaging Acquisition for Spinal Cord Assessment,” with Response from Dr Martín Noguerol et alRadioGraphics2020Volume: 40Issue: 2pp. 428-431Impact of Data-driven Respiratory Gating in Clinical PETRadiology2016Volume: 281Issue: 1pp. 229-238Validation of Software Gating: A Practical Technology for Respiratory Motion Correction in PETRadiology2016Volume: 281Issue: 1pp. 239-248MR Neurography of Peripheral Nerve Injury in the Presence of Orthopedic Hardware: Technical ConsiderationsRadiology2021Volume: 300Issue: 2pp. 246-259See More RSNA Education Exhibits A Primer on Commonly Occurring MRI Artifacts and How to Overcome ThemDigital Posters2020Up-to-Date Technique for Improvement of CT and MRI Imaging Quality in the Head and Neck: Theory, Clinical ApplicationsDigital Posters2019Pulse Sequences Used in Musculoskeletal MRI Exams: A Review for Residents and FellowsDigital Posters2018 RSNA Case Collection Orbital blowout fractureRSNA Case Collection2020Metastatic invasive lobular breast carcinomaRSNA Case Collection2021Pulmonary SequestrationRSNA Case Collection2022 Vol. 42, No. 3 Slide PresentationMetrics Altmetric Score PDF download

Meeting abstracts from the 15th international conference on neonatal and childhood pulmonary vascular disease

Meeting abstracts from the 15th international conference on neonatal and childhood pulmonary vascular disease

A Tachycardia in Disguise.

A Tachycardia in Disguise.

Equipoise in Clinical Trials: Enough Uncertainty in Whose Opinion?

Equipoise in Clinical Trials: Enough Uncertainty in Whose Opinion?

High-Frequency, Low-Tidal-Volume Mechanical Ventilation Safely Improves Catheter Stability and Procedural Efficiency During Radiofrequency Ablation of Atrial Fibrillation

High-Frequency, Low-Tidal-Volume Mechanical Ventilation Safely Improves Catheter Stability and Procedural Efficiency During Radiofrequency Ablation of Atrial Fibrillation

Hemophagocytic Lymphohistiocytosis Associated With Endocarditis: A Case Years in the Making.

Hemophagocytic Lymphohistiocytosis Associated With Endocarditis: A Case Years in the Making.

"Like Any Other Camp": Experiences and lessons learned from an integrated day camp for children with heart disease.

Summer camps for children living with heart disease can have a profound impact on well-being. However, specialized camps often require extensive resources (i.e., 24-hmedical staff supervision) and may be located in farremote settings. Integrating children with heart disease into mainstream day camps may address these barriers. The purpose of this study is to describe the experience of attending an integrated day camp from the perspectives of children with heart disease and their parents. This study used a qualitative descriptive design. Among 25 eligible families, 9 participated in interviews which were held 3 months to 2 years after attending an integrated camp (mean age of children at camp was 7.3 ± 2.25 years). Interviews were audio-recorded and transcribed verbatim for an inductive thematic analysis. Many parents chose the integrated camp as their child's first summer camp experience, citing trust in the local division of Cardiology's approval of the camp activities as an important reason for enrolling. All participants agreed the integrated camp was a valued opportunity which should continue, although not all described positive camp experiences. Participants' descriptions of the integrated camp were organized into two main themes: 1) overall expectations of the camp and 2) important opportunities afforded by the camp experience. Partaking in a typical camp experience, connecting to local children with heart disease, adequate safety precautions and activity adaptations were specific expectations held by participants. Important opportunities included greater independence and confidence, navigating disclosure of their diagnosis to peers on their own terms, and more diverse social connections. Improving communication with parents to ensure expectations match camp objectives would have enhanced the experience. Practitioners looking for an alternative to specialized camps for their patients with heart disease may use these results to guide the design and promotion of an integrated camp.

CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?

HomeCirculationVol. 145, No. 10CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine? No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextCYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine? Dimitri J. Maamari, MD, Farouc A. Jaffer, MD, PhD, Amit V. Khera, MD, MSc and Akl C. Fahed, MD, MPH Dimitri J. MaamariDimitri J. Maamari https://orcid.org/0000-0003-2797-9370 Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.). Search for more papers by this author , Farouc A. JafferFarouc A. Jaffer https://orcid.org/0000-0001-7980-384X Division of Cardiology (F.A.J., A.V.K., A.C.F.), Department of Medicine, Massachusetts General Hospital Cardiovascular Research Center, Cardiology Division (F.A.J., A.C.F.), Massachusetts General Hospital Department of Medicine, Harvard Medical School (F.A.J., A.V.K., A.C.F.) Boston. Search for more papers by this author , Amit V. KheraAmit V. Khera https://orcid.org/0000-0001-6535-5839 Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital Division of Cardiology (F.A.J., A.V.K., A.C.F.), Department of Medicine, Massachusetts General Hospital Department of Medicine, Harvard Medical School (F.A.J., A.V.K., A.C.F.) Boston. Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.). Search for more papers by this author and Akl C. FahedAkl C. Fahed Correspondence to: Akl C. Fahed, MD, MPH, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, CPZN 3.218, Boston, MA 02114. Email E-mail Address: [email protected] https://orcid.org/0000-0002-4849-6389 Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital Division of Cardiology (F.A.J., A.V.K., A.C.F.), Department of Medicine, Massachusetts General Hospital Cardiovascular Research Center, Cardiology Division (F.A.J., A.C.F.), Massachusetts General Hospital Department of Medicine, Harvard Medical School (F.A.J., A.V.K., A.C.F.) Boston. Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.). Search for more papers by this author Originally published7 Mar 2022https://doi.org/10.1161/CIRCULATIONAHA.121.057028Circulation. 2022;145:721–723FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 723.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Akl C. Fahed, MD, MPH, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, CPZN 3.218, Boston, MA 02114. Email [email protected]harvard.edu

An Interactive, Multimodal Curriculum to Teach Pediatric Cardiology to House Staff.

Pediatricians must be able to diagnose, triage, and manage infants and children with congenital heart disease. The pediatric cardiology division at the Medical University of South Carolina updated their curriculum for pediatric residents to a format supported by constructivist learning theory. The purpose of this study is to determine if shorter, interactive learning with fellow and faculty involvement improved pediatric cardiology knowledge demonstrated through test scores and resident satisfaction. A curriculum of short lectures and interactive workshops was delivered over 6 weeks in August and September 2018. Residents answered a 10-question pretest prior to the curriculum, followed by a post-test immediately after the last session and a delayed post-test 8 months later. Residents also provided summative feedback on the educational sessions. Sixty-six residents were eligible to participate in the curriculum with 44 (67%) completing the pretest, 40 (61%) completing the post-test, and 33 (50%) completing the delayed post-test. The mean score increased significantly from 56 to 68% between the pretest and post-test (p = 0.0018). The delayed post-test mean score remained high at 71% without significant change (p = 0.46). Overall feedback was positive highlighting the interactive nature of lectures and the participation of cardiology fellows. Using an interactive, multimodal educational series, pediatric residents had a significant increase in pediatric cardiology test scores and demonstrated good retention.

What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine?

HomeCirculationVol. 145, No. 9What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine? No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextWhat Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine? Patrick R. Lawler, MD, MPH, Judith S. Hochman, MD, MA and Ryan Zarychanski, MD, MSc Patrick R. LawlerPatrick R. Lawler Correspondence to: Patrick R. Lawler, MD, MPH, Peter Munk Cardiac Centre, Toronto General Hospital, RFE3-410, 190 Elizabeth St, Toronto, ON, Canada M5G 2C4. Email E-mail Address: [email protected] https://orcid.org/0000-0001-5155-5071 Peter Munk Cardiac Centre, Toronto General Hospital, Canada (P.R.L.). Division of Cardiology and Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada (P.R.L.). Search for more papers by this author , Judith S. HochmanJudith S. Hochman https://orcid.org/0000-0002-5889-5981 Cardiovascular Clinical Research Center and Division of Cardiology, New York University Langone Health, New York University Grossman School of Medicine (J.S.H.). Search for more papers by this author and Ryan ZarychanskiRyan Zarychanski University of Manitoba, Max Rady College of Medicine, Department of Internal Medicine, Sections of Hematology/Medical Oncology and Critical Care, Winnipeg, Canada (R.Z). CancerCare Manitoba, Department of Medical Oncology and Hematology, Winnipeg, Canada (R.Z.). Search for more papers by this author Originally published28 Feb 2022https://doi.org/10.1161/CIRCULATIONAHA.121.058113Circulation. 2022;145:629–632FootnotesCirculation is available at www.ahajournals.org/journal/circThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 632.Correspondence to: Patrick R. Lawler, MD, MPH, Peter Munk Cardiac Centre, Toronto General Hospital, RFE3-410, 190 Elizabeth St, Toronto, ON, Canada M5G 2C4. Email patrick.[email protected]ca

Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure

BackgroundThe association between serum uric acid (SUA) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in patients with coronary artery disease (CAD) is unclear. MethodsWe retrospectively studied 171 patients with suspected or established CAD and without overt heart failure who were consecutively admitted to our Division of Cardiology from February to August 2016. Plasma NT-proBNP concentrations were measured using a chemiluminescent immunoassay method. A conventional echocardiography and coronary angiogram were also performed in all patients. ResultsPatients in the 3rd SUA tertile had higher median plasma NT-proBNP concentrations compared with those belonging to 2nd or 1st SUA tertile, respectively (443 [IQR: 222–1381] vs. 224 [99–487] vs. 162 [68–307] pg/mL; p < 0.001). After adjustment for age, sex, body mass index, hypertension, diabetes, chronic kidney disease, prior ischemic heart disease, prior heart failure, medication use, and left ventricular ejection fraction (LVEF), patients belonging to the 3rd SUA tertile had an increased risk of higher plasma NT-proBNP concentrations (adjusted-standardized beta coefficient: 0.310, p < 0.001). Almost identical results were found when patients treated with allopurinol (n = 14), or those with prior HF (n = 8) were excluded from the analyses. ConclusionsThese results show that increased SUA levels are strongly associated with higher plasma NT-proBNP concentrations in patients with suspected or established CAD and without overt heart failure, independent of established cardiovascular risk factors, LVEF, medication use and other potential confounders.

Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome.

Background: This paper aims to evaluate the concordance between the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula and alternative equations and to assess their predictive power for all-cause mortality in unselected patients discharged alive from a cardiology ward. Methods: We retrospectively included patients admitted to our Cardiology Division independently of their diagnosis. The total population was classified according to Kidney Disease: Improving Global Outcomes (KDIGO) categories, as follows: G1 (estimated glomerular filtration rate (eGFR) ≥90 mL/min/1.73 m2); G2 (eGFR 89–60 mL/min/1.73 m2); G3a (eGFR 59–45 mL/min/1.73 m2); G3b (eGFR 44–30 mL/min/1.73 m2); G4 (eGFR 29–15 mL/min/1.73 m2); G5 (eGFR <15 mL/min/1.73 m2). Cockcroft-Gault (CG), CG adjusted for body surface area (CG-BSA), Modification of Diet in Renal Disease (MDRD), Berlin Initiative Study (BIS-1), and Full Age Spectrum (FAS) equations were also assessed. Results: A total of 806 patients were included. Good agreement was found between the CKD-EPI formula and CG-BSA, MDRD, BIS-1, and FAS equations. In subjects younger than 65 years or aged ≥85 years, CKD-EPI and MDRD showed the highest agreement (Cohen’s kappa (K) 0.881 and 0.588, respectively) while CG showed the lowest. After a median follow-up of 407 days, overall mortality was 8.2%. The risk of death was higher in lower eGFR classes (G3b HR4.35; 95%CI 1.05–17.80; G4 HR7.13; 95%CI 1.63–31.23; G5 HR25.91; 95%CI 6.63–101.21). The discriminant capability of death prediction tested with ROC curves showed the best results for BIS-1 and FAS equations. Conclusion: In our cohort, the concordance between CKD-EPI and other equations decreased with age, with the MDRD formula showing the best agreement in both younger and older patients. Overall, mortality rates increased with the renal function decreasing. In patients aged ≥75 years, the best discriminant capability for death prediction was found for BIS-1 and FAS equations.

Grace Under Pressure.

Grace Under Pressure.

Clinical implications of assessing frailty in elderly patients treated with permanent cardiac pacing

aCardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena bClinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy Correspondence to Professor Giuseppe Boriani, MD, PhD, FESC, FEHRA, Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, 41124 Modena, Italy Tel: +39 59 4225836; fax: +39 59 4224498; e-mail: [email protected] Received 12 May, 2021 Accepted 29 May, 2021

"My Amazing Heart": A Patient's Simple Request to Change Outdated Heart Failure Labels.

HomeCirculation: Heart FailureVol. 15, No. 3“My Amazing Heart”: A Patient’s Simple Request to Change Outdated Heart Failure Labels No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull Text“My Amazing Heart”: A Patient’s Simple Request to Change Outdated Heart Failure Labels Peter K. Boulos, MD, MS, Gary Burgin, Rachel Johnson-Koenke, PhD, LCSW and Kelsey M. Flint, MD, MSCS Peter K. BoulosPeter K. Boulos Correspondence to: Peter K. Boulos, MD, MS, Division of Cardiology, University of Colorado School of Medicine, 12631 E 17th Ave, B130, Aurora, CO 80045. Email E-mail Address: [email protected] https://orcid.org/0000-0002-1970-6439 Division of Cardiology, University of Colorado School of Medicine, Aurora (P.K.B., K.M.F.). Search for more papers by this author , Gary BurginGary Burgin https://orcid.org/0000-0001-7905-2652 Search for more papers by this author , Rachel Johnson-KoenkeRachel Johnson-Koenke https://orcid.org/0000-0001-9989-2085 Rocky Mountain Regional Veterans Administration Medical Center, Aurora, CO (R.J.-K., K.M.F.). University of Colorado College of Nursing, Aurora (R.J.-K.). Search for more papers by this author and Kelsey M. FlintKelsey M. Flint https://orcid.org/0000-0003-3185-2356 Division of Cardiology, University of Colorado School of Medicine, Aurora (P.K.B., K.M.F.). Rocky Mountain Regional Veterans Administration Medical Center, Aurora, CO (R.J.-K., K.M.F.). Search for more papers by this author Originally published14 Jan 2022https://doi.org/10.1161/CIRCHEARTFAILURE.121.008679Circulation: Heart Failure. 2022;15:e008679FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 286.Correspondence to: Peter K. Boulos, MD, MS, Division of Cardiology, University of Colorado School of Medicine, 12631 E 17th Ave, B130, Aurora, CO 80045. Email peter.[email protected]edu

Sex-specific differences in trimethylamine N-oxide (TMAO) concentrations before and after cardiac rehabilitation in acute myocardial infarction patients.

Trimethylamine N-oxide (TMAO) is a biomarker of cardiovascular risk and may enhance the progression of atherosclerosis. The aim of the study was to determine whether there are sex-specific differences in TMAO concentrations before and after cardiac rehabilitation in acute myocardial infarction (AMI) patients. A total of 56 participants [45/56 (80.4 %) males, 11/56 (19.6 %) females] were drawn from AMI inpatients hospitalized at the Division of Cardiology, Medical University of Graz, Austria. For the assessment of TMAO, serum samples were collected within the first day after hospital admission due to AMI and at the start and end of cardiac rehabilitation. Shortly after hospital admission due to AMI, females had significantly higher TMAO blood concentrations than males. These initially high TMAO levels remained almost unchanged in the female AMI patients until the start of cardiac rehabilitation and only reached the lower TMAO concentrations observed in the male patients after rehabilitation [female patients: TMAO (acute myocardial infarction) = 5.93 μmol/L (SE = 1.835); TMAO (start of rehabilitation) = 5.68 μmol/L (SE = 1.217); TMAO (end of rehabilitation) = 3.89 μmol/L (SE = 0.554); male patients: TMAO (acute myocardial infarction) = 3.02 μmol/L (SE = 0.255), TMAO (start of rehabilitation) = 3.91 μmol/L (SE = 0.346), TMAO (end of rehabilitation) = 4.04 μmol/L (SE = 0.363)]. After AMI, women might be at higher cardiovascular risk due to persistently higher levels of TMAO. High TMAO levels in women might decrease after cardiac rehabilitation due to cardiac rehabilitation-associated lifestyle modifications. These lifestyle modifications after AMI might also prevent increases in TMAO concentrations in men.

Cardiology

Significant advances have been made in 2021 in the areas of interventional cardiology, heart failure, cardiac imaging, electrophysiology and congenital heart disease. In addition to improving the screening, diagnosis and management of many heart diseases, these advances will change our daily practice. Moreover, the European Society of Cardiology has updated its guidelines on heart failure, valve disease, cardiac pacing and cardiovascular disease prevention. As in previous years, members of the Cardiology division of Lausanne University Hospital (CHUV) came together to select and present to you the papers that they considered to be the most important of the past year.

Improving Outcomes for Women With Heart Disease: Implications for Nurse Practitioners

Each year the first Friday of February is designated National Wear Red Day® by the American Heart Association to raise awareness that cardiovascular disease (CVD) is the number cause of death and disability for women. 1 American Heart AssociationGo Red for Women®: Wear Red and Give. https://www.goredforwomen.org/en/get-involved/give/wear-red-and-giveDate accessed: November 18, 2021 Google Scholar Despite the fact that approximately 335,000 women are hospitalized yearly for acute coronary syndrome, the acute manifestation of coronary artery disease (CAD), 2 Virani S.S. Alonso A. Benjamin E.J. et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020; 141: e139-e596https://doi.org/10.1161/CIR.0000000000000757 Crossref PubMed Scopus (2259) Google Scholar the significance of CVD in women is largely underappreciated. Furthermore, care provided for women with CVD continues to be based heavily on men’s experiences because far fewer women have been enrolled in cardiovascular studies to date. 3 Jin X. Chandramouli C. Allocco B. Gong E. Lam C.S.P. Yan L.L. Women’s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020; 141: 540-548https://doi.org/10.1161/CIRCULATIONAHA.119.043594 Crossref PubMed Scopus (47) Google Scholar This partially explains why women with CVD experience worse outcomes compared with men. 2 Virani S.S. Alonso A. Benjamin E.J. et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020; 141: e139-e596https://doi.org/10.1161/CIR.0000000000000757 Crossref PubMed Scopus (2259) Google Scholar Leslie L. Davis, PhD, ANP-BC, is an associate professor at the University of North Carolina at Chapel Hill. Dr. Davis teaches research and evidence-based practice and maintains a part-time nurse practitioner position in the Division of Cardiology at the University of North Carolina at Chapel Hill School of Medicine. She can be reached at [email protected] .

Identification of Circumferential Pulmonary Vein Isolation Gaps and Critical Atrial Substrate From HD Grid Maps in Atrial Fibrillation Patients: Insights From Omnipolar Technology

Identification of Circumferential Pulmonary Vein Isolation Gaps and Critical Atrial Substrate From HD Grid Maps in Atrial Fibrillation Patients: Insights From Omnipolar Technology

Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension.

HomeCirculation: Cardiovascular InterventionsVol. 15, No. 1Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension No AccessCase ReportRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyRedditDiggEmail Jump toSupplementary MaterialsNo AccessCase ReportRequest AccessFull TextTranscatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension Jason H. Anderson, MD, Allison K. Cabalka, MD, Robert P. Frantz, MD, Hector R. Cajigas, MD and Nathaniel W. Taggart, MD Jason H. AndersonJason H. Anderson Correspondence to: Jason H. Anderson, MD, Mayo Clinic, Rochester, MN 55905. Email E-mail Address: [email protected] https://orcid.org/0000-0002-3941-0707 Division of Pediatric Cardiology (J.H.A., A.K.C., N.W.T.), Mayo Clinic, Rochester MN. Department of Cardiovascular Diseases (J.H.A., A.K.C., R.P.F., N.W.T.), Mayo Clinic, Rochester MN. Search for more papers by this author , Allison K. CabalkaAllison K. Cabalka Division of Pediatric Cardiology (J.H.A., A.K.C., N.W.T.), Mayo Clinic, Rochester MN. Department of Cardiovascular Diseases (J.H.A., A.K.C., R.P.F., N.W.T.), Mayo Clinic, Rochester MN. Search for more papers by this author , Robert P. FrantzRobert P. Frantz https://orcid.org/0000-0003-4128-3978 Department of Cardiovascular Diseases (J.H.A., A.K.C., R.P.F., N.W.T.), Mayo Clinic, Rochester MN. Search for more papers by this author , Hector R. CajigasHector R. Cajigas https://orcid.org/0000-0002-6792-1280 Division of Pulmonary and Critical Care (H.R.C.), Mayo Clinic, Rochester MN. Search for more papers by this author and Nathaniel W. TaggartNathaniel W. Taggart https://orcid.org/0000-0002-7424-8207 Division of Pediatric Cardiology (J.H.A., A.K.C., N.W.T.), Mayo Clinic, Rochester MN. Department of Cardiovascular Diseases (J.H.A., A.K.C., R.P.F., N.W.T.), Mayo Clinic, Rochester MN. Search for more papers by this author Originally published21 Dec 2021https://doi.org/10.1161/CIRCINTERVENTIONS.121.011315Circulation: Cardiovascular Interventions. 2022;15:e011315FootnotesSupplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/CIRCINTERVENTIONS.121.011315.For Sources of Funding and Disclosures, see page 112.Correspondence to: Jason H. Anderson, MD, Mayo Clinic, Rochester, MN 55905. Email anderson.[email protected]edu